SCHEMBL26913617

SCHEMBL26913617

Cc1ccc(S(=O)(=O)n2ccc3c(NC(=O)OC(C)(C)C)cc(Cl)c(F)c32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PPARD Q03181 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ PDE4A P27815 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ RORC P51449 12/20 0.36
▸ MMP8 P22894 2/20 0.36
▸ MMP3 P08254 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26912756 0.90 MEN1 (0.39) MEN1POLBKMT2APPARGPPARD
SCHEMBL26913621 0.87 PPARG (0.41) MEN1KMT2APPARGPPARDPPARA
SCHEMBL30684152 0.81 KMT2A (0.43) MEN1POLBKMT2APPARGPPARD
SCHEMBL31110988 0.77 HCRTR1 (0.37) MEN1POLBKMT2ARORCMMP8
SCHEMBL26912354 0.77 BRD4 (0.39) MEN1POLBKMT2APDE4APDE4B
SCHEMBL26913270 0.76 PPARG (0.43) MEN1KMT2APPARGPPARDPPARA
SCHEMBL26913112 0.74 CA1 (0.40) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL15374350 0.72 MEN1 (0.46) MEN1POLBKMT2APPARGPPARD
SCHEMBL15374349 0.70 MEN1 (0.47) MEN1POLBKMT2APPARGPPARD
SCHEMBL26913637 0.70 BRD4 (0.35) POLBPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235809-A1 CGAS INHIBITORS ELI LILLY AND COMPANY (US) 2023-12-07 — — WO disclosed
US-20230391786-A1 cGAS INHIBITORS ELI LILLY AND COMPANY 2023-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391786-A1 cGAS INHIBITORS CGAS, STING1, TBK1 MEN1 2408/4885POLB 245/4885KMT2A 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback